| Home > Zentren > Zentrum für Operative Medizin > Klinik und Poliklinik für Urologie > Publikationen 2011

Publikationen 2011

Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy.

Abdollah F, Sun M, Briganti A, Thuret R, Schmitges J, Gallina A, Suardi N, Capitanio U, Salonia A, Shariat SF, Perrotte P, Rigatti P, Montorsi F, Karakiewicz PI.

BJU Int. 2011 Dec;108(11):1769-75. doi: 10.1111/j.1464-410X.2011.10204.x. Epub 2011 Apr 20.

PMID: 21507189 [PubMed - indexed for MEDLINE]

Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.

Abdollah F, Schmitges J, Sun M, Thuret R, Djahangirian O, Tian Z, Shariat SF, Briganti A, Perrotte P, Montorsi F, Karakiewicz PI.

Urology. 2011 Dec;78(6):1363-7.

PMID: 22137704 [PubMed - indexed for MEDLINE]

Discharge patterns after radical prostatectomy in the United States of America.

Trinh QD, Bianchi M, Sun M, Sammon J, Schmitges J, Shariat SF, Sukumar S, Jeldres C, Zorn K, Perrotte P, Rogers CG, Peabody JO, Montorsi F, Menon M, Karakiewicz PI.

Urol Oncol. 2011 Nov 17. [Epub ahead of print]

PMID: 22100070 [PubMed - as supplied by publisher]

Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.

Trinh QD, Schmitges J, Bianchi M, Sun M, Shariat SF, Sammon J, Jeldres C, Zorn K, Sukumar S, Perrotte P, Graefen M, Rogers CG, Peabody JO, Menon M, Karakiewicz PI.

BJU Int. 2011 Nov 1. doi: 10.1111/j.1464-410X.2011.10701.x. [Epub ahead of print]

PMID: 22044638 [PubMed - as supplied by publisher]

Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.

Abdollah F, Sun M, Schmitges J, Tian Z, Jeldres C, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI.

Eur Urol. 2011 Nov;60(5):920-30. Epub 2011 Jun 29.

PMID: 21741762 [PubMed - indexed for MEDLINE]

Radical prostatectomy at academic versus nonacademic institutions: a population based analysis.

Trinh QD, Schmitges J, Sun M, Shariat SF, Sukumar S, Bianchi M, Tian Z, Jeldres C, Sammon J, Perrotte P, Graefen M, Peabody JO, Menon M, Karakiewicz PI.

J Urol. 2011 Nov;186(5):1849-54. Epub 2011 Sep 25.

PMID: 21944081 [PubMed - in process]

Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.

Abdollah F, Sun M, Thuret R, Schmitges J, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI.

Ann Surg Oncol. 2011 Oct;18(10):2988-96. Epub 2011 Apr 16.

PMID: 21499808 [PubMed - indexed for MEDLINE]

Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA.

Sun M, Abdollah F, Schmitges J, Bianchi M, Tian Z, Shariat SF, Zorn K, Pharand D, Widmer H, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.

BJU Int. 2011 Sep 27. doi: 10.1111/j.1464-410X.2011.10569.x. [Epub ahead of print]

PMID: 21951647 [PubMed - as supplied by publisher]

Does partial nephrectomy at an academic institution result in better outcomes?

Trinh QD, Schmitges J, Sun M, Sammon J, Shariat SF, Sukumar S, Zorn K, Bianchi M, Jeldres C, Perrotte P, Graefen M, Rogers CG, Peabody JO, Menon M, Karakiewicz PI.

World J Urol. 2011 Sep 9. [Epub ahead of print]

PMID: 21904920 [PubMed - as supplied by publisher]

Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.

Abdollah F, Schmitges J, Sun M, Thuret R, Djahangirian O, Jeldres C, Shariat SF, Graefen M, Perrotte P, Montorsi F, Karakiewicz PI.

J Urol. 2011 Sep;186(3):824-8. Epub 2011 Jul 23.

PMID: 21788051 [PubMed - indexed for MEDLINE]

Conditional survival predictions after surgery for patients with penile carcinoma.

Thuret R, Sun M, Abdollah F, Schmitges J, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.

Cancer. 2011 Aug 15;117(16):3723-30. doi: 10.1002/cncr.25974. Epub 2011 Feb 24.

PMID: 21360525 [PubMed - indexed for MEDLINE]

Surgery for high-risk localized prostate cancer.

Schmitges J, Trinh QD, Walz J, Graefen M.

Ther Adv Urol. 2011 Aug;3(4):173-82.

PMID: 21969847 [PubMed]

The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.

Abdollah F, Sun M, Shariat SF, Schmitges J, Djahangirian O, Tian Z, Jeldres C, Perrotte P, Montorsi F, Karakiewicz PI.

J Urol. 2011 Jun;185(6):2078-84. Epub 2011 Apr 15.

PMID: 21496836 [PubMed - indexed for MEDLINE]

Related citations

A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study.

Abdollah F, Schmitges J, Sun M, Tian Z, Briganti A, Shariat SF, Perrotte P, Montorsi F, Karakiewicz PI.

Prostate. 2011 Apr 7. doi: 10.1002/pros.21376. [Epub ahead of print]

PMID: 21480307 [PubMed - as supplied by publisher]

Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.

Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, Shariat SF, Montorsi F, Patard JJ, Perrotte P, Karakiewicz PI.

Eur Urol. 2011 Jan;59(1):135-41. Epub 2010 Oct 28.

PMID: 21035250 [PubMed - indexed for MEDLINE]

Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.

Sun M, Abdollah F, Bianchi M, Trinh QD, Shariat SF, Jeldres C, Tian Z, Hansen J, Briganti A, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI.

Eur J Cancer. 2011 Dec 21. [Epub ahead of print]

PMID: 22196034 [PubMed - as supplied by publisher]

Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.

Nuhn P, Bastian PJ, Novara G, Svatek RS, Karakiewicz PI, Skinner E, Fradet Y, Izawa JI, Kassouf W, Montorsi F, Müller SC, Fritsche HM, Sonpavde G, Tilki D, Isbarn H, Ficarra V, Dinney CP, Shariat SF.

Urol Int. 2011;87(1):42-8. Epub 2011 Jun 9.

PMID: 21659717 [PubMed - indexed for MEDLINE]

Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort.

Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, Kamat AM, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Dinney CP.

BJU Int. 2011 Mar;107(6):898-904. doi: 10.1111/j.1464-410X.2010.09628.x. Epub 2011 Jan 18.

PMID: 21244604 [PubMed - indexed for MEDLINE]

Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: results from a contemporary European patient cohort.

Seiler D, Randazzo M, Klotz L, Grobholz R, Baumgartner M, Isbarn H, Recker F, Kwiatkowski M.

BJU Int. 2011 Nov 17. doi: 10.1111/j.1464-410X.2011.10707.x. [Epub ahead of print]

PMID: 22093744 [PubMed - as supplied by publisher]

Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.

Walz J, Joniau S, Chun FK, Isbarn H, Jeldres C, Yossepowitch O, Chao-Yu H, Klein EA, Scardino PT, Reuther A, Poppel HV, Graefen M, Huland H, Karakiewicz PI.

BJU Int. 2011 Mar;107(5):765-70. doi: 10.1111/j.1464-410X.2010.09594.x. Epub 2010 Sep 28.

PMID: 20875089 [PubMed - indexed for MEDLINE]

Genomic profiling of cell-free DNA in blood and bone marrow of prostate cancer patients.

Schwarzenbach H, Chun FK, Isbarn H, Huland H, Pantel K.

J Cancer Res Clin Oncol. 2011 May;137(5):811-9. Epub 2010 Aug 4.

PMID: 20683729 [PubMed - indexed for MEDLINE]

Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score.

Huang Y, Isharwal S, Haese A, Chun FK, Makarov DV, Feng Z, Han M, Humphreys E, Epstein JI, Partin AW, Veltri RW.

BJU Int. 2011 May;107(10):1562-9. doi: 10.1111/j.1464-410X.2010.09692.x. Epub 2010 Sep 28. Erratum in: BJU Int. 2011 Oct;108(7):1232.

Clinical evaluation of the PCA3 assay in guiding initial biopsy decisions.

de la Taille A, Irani J, Graefen M, Chun F, de Reijke T, Kil P, Gontero P, Mottaz A, Haese A.

J Urol. 2011 Jun;185(6):2119-25. Epub 2011 Apr 15.

PMID: 21496856 [PubMed - indexed for MEDLINE]

Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.

Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF.

World J Urol. 2011 Aug;29(4):473-80. Epub 2011 Apr 17.

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

Auprich M, Bjartell A, Chun FK, de la Taille A, Freedland SJ, Haese A, Schalken J, Stenzl A, Tombal B, van der Poel H.

Eur Urol. 2011 Nov;60(5):1045-54. Epub 2011 Aug 25. Review.

PMID: 21871709 [PubMed - indexed for MEDLINE]

The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy.

Schmitges J, Trinh QD, Bianchi M, Sun M, Abdollah F, Ahyai SA, Jeldres C, Steuber T, Perrotte P, Shariat SF, Menon M, Montorsi F, Graefen M, Karakiewicz PI.

Int Urol Nephrol. 2011 Dec 13. [Epub ahead of print]

PMID: 22160759 [PubMed - as supplied by publisher]

Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities.

De Nunzio C, Ahyai S, Autorino R, Bachmann A, Bialek W, Briganti A, Reich O, Sosnowski R, Thiruchelvam N, Novara G; European Association of Urology Young Academic Urologists BPH Group.

Eur Urol. 2011 Dec;60(6):1205-6. Epub 2011 Sep 7. No abstract available.

PMID: 21930341 [PubMed - indexed for MEDLINE]

Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma.

Hellwinkel OJ, Asong LE, Rogmann JP, Sültmann H, Wagner C, Schlomm T, Eichelberg C.

Prostate Cancer Prostatic Dis. 2011 Mar;14(1):38-45. Epub 2010 Nov 23.

Full functional-length urethral sphincter preservation during radical prostatectomy.

Schlomm T, Heinzer H, Steuber T, Salomon G, Engel O, Michl U, Haese A, Graefen M, Huland H.

Eur Urol. 2011 Aug;60(2):320-9. Epub 2011 Mar 22.

PMID: 21458913 [PubMed - indexed for MEDLINE]

Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.

Rink M, Chun FK, Minner S, Friedrich M, Mauermann O, Heinzer H, Huland H, Fisch M, Pantel K, Riethdorf S.

BJU Int. 2011 May;107(10):1668-75. doi: 10.1111/j.1464-410X.2010.09562.x. Epub 2010 Aug 24.

PMID: 20735381 [PubMed - indexed for MEDLINE]

Older patients suffer from adverse histopathological features after radical cystectomy.

Rink M, Dahlem R, Kluth L, Minner S, Ahyai SA, Eichelberg C, Fisch M, Chun FKH.

Int J Urol. 2011 Aug;18(8):576-84. doi: 10.1111/j.1442-2042.2011.02794.x. Epub 2011 Jun 23.

PMID: 21699582 [PubMed - indexed for MEDLINE]

Open retropubic reanastomosis for highly recurrent and complex bladder neck stenosis.

Pfalzgraf D, Beuke M, Isbarn H, Reiss CP, Meyer-Moldenhauer WH, Dahlem R, Fisch M.

J Urol. 2011 Nov;186(5):1944-7. Epub 2011 Sep 23.

PMID: 21944115 [PubMed - in process]

Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma.

Eichelberg C, Minner S, Isbarn H, Burandt E, Terracciano L, Moch H, Kell A, Heuer R, Chun FK, Sauter G, Fisch M, Tennstedt P.

World J Urol. 2011 Oct 19. [Epub ahead of print]

PMID: 22009118 [PubMed - as supplied by publisher]

Tissue-based molecular markers for renal cell carcinoma.

Rink M, Chun FK, Robinson B, Sun M, Karakiewicz PI, Bensalah K, Fisch M, Scherr DS, Lee RK, Margulis V, Shariat SF.

Minerva Urol Nefrol. 2011 Dec;63(4):293-308.

PMID: 21996985 [PubMed - in process]

Reconstructive surgery.

Fisch M.

Curr Opin Urol. 2011 Nov;21(6):447-8. No abstract available.

PMID: 21941184 [PubMed - indexed for MEDLINE]

Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.

Sun M, Abdollah F, Budäus L, Liberman D, Tian Z, Morgan M, Johal R, Schmitges J, Shariat SF, Montorsi F, Greafen M, Perrotte P, Karakiewicz PI.

Ann Surg Oncol. 2011 Oct;18(10):2997-3004. Epub 2011 Apr 21.

PMID: 21509630 [PubMed - indexed for MEDLINE]

Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade.

Budäus L, Spethmann J, Isbarn H, Schmitges J, Beesch L, Haese A, Salomon G, Schlomm T, Fisch M, Heinzer H, Huland H, Graefen M, Steuber T.

BJU Int. 2011 Oct;108(8):1256-61. doi: 10.1111/j.1464-410X.2010.09982.x. Epub 2011 Jan 18.

PMID: 21244612 [PubMed - indexed for MEDLINE]

The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study.

Budäus L, Abdollah F, Sun M, Johal R, Morgan M, Thuret R, Zorn KC, Lughezzani G, Isbarn H, Haese A, Shariat SF, Montorsi F, Perrotte P, Graefen M, Karakiewicz PI.

BJU Int. 2011 Sep;108(6):888-93. doi: 10.1111/j.1464-410X.2010.09906.x. Epub 2010 Dec 13.

PMID: 21156018 [PubMed - indexed for MEDLINE]

A population-based analysis of temporal perioperative complication rates after minimally invasive radical prostatectomy.

Schmitges J, Trinh QD, Abdollah F, Sun M, Bianchi M, Budäus L, Zorn K, Perotte P, Schlomm T, Haese A, Montorsi F, Menon M, Graefen M, Karakiewicz PI.

Eur Urol. 2011 Sep;60(3):564-71. Epub 2011 Jun 25.

PMID: 21723034 [PubMed - indexed for MEDLINE]

Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.

Steuber T, Budäus L, Walz J, Zorn KC, Schlomm T, Chun F, Ahyai S, Fisch M, Sauter G, Huland H, Graefen M, Haese A.

BJU Int. 2011 Jun;107(11):1755-61. doi: 10.1111/j.1464-410X.2010.09730.x. Epub 2010 Oct 13.

PMID: 20942833 [PubMed - indexed for MEDLINE]

Controversies in the management of localized prostate cancer: Radical prostatectomy still the standard of care.

Budäus L, Huland H, Graefen M; on behalf of AROME, Association of Radiotherapy and Oncology of the Mediterranean arEa.

Crit Rev Oncol Hematol. 2011 May 23. [Epub ahead of print]

PMID: 21612943 [PubMed - as supplied by publisher]

Impact of annual surgical volume on length of stay in patients undergoing minimally invasive prostatectomy: a population-based study.

Budäus L, Morgan M, Abdollah F, Zorn KC, Sun M, Johal R, Thuret R, Abdo A, Schmitges J, Isbarn H, Jeldres C, Perrotte P, Graefen M, Karakiewicz PI.

Eur J Surg Oncol. 2011 May;37(5):429-34.

PMID: 21492776 [PubMed - indexed for MEDLINE]

Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based study.

Budäus L, Sun M, Abdollah F, Zorn KC, Morgan M, Johal R, Liberman D, Thuret R, Isbarn H, Salomon G, Haese A, Montorsi F, Shariat SF, Perrotte P, Graefen M, Karakiewicz PI.

Ann Surg Oncol. 2011 Mar;18(3):839-47. Epub 2010 Oct 16.

PMID: 20953720 [PubMed - indexed for MEDLINE]

Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.

Liberman D, Alasker A, Sun M, Ismail S, Lughezzani G, Jeldres C, Budaus L, Thuret R, Shariat SF, Widmer H, Perrotte P, Graefen M, Montorsi F, Karakiewicz PI.

BJU Int. 2011 Mar;107(6):905-11. doi: 10.1111/j.1464-410X.2010.09590.x. Epub 2010 Sep 22.

PMID: 20860649 [PubMed - indexed for MEDLINE]

Impact of caseload on total hospital charges: a direct comparison between minimally invasive and open radical prostatectomy--a population based study.

Abdollah F, Budäus L, Sun M, Morgan M, Johal R, Thuret R, Zorn KC, Isbarn H, Haese A, Jeldres C, Perrotte P, Montorsi F, Graefen M, Karakiewicz PI.

J Urol. 2011 Mar;185(3):855-61. Epub 2011 Jan 15.

PMID: 21238994 [PubMed - indexed for MEDLINE]

Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.

Liberman D, Lughezzani G, Sun M, Alasker A, Thuret R, Abdollah F, Budaus L, Widmer H, Graefen M, Montorsi F, Shariat SF, Perrotte P, Karakiewicz PI.

Urology. 2011 Mar;77(3):660-6. Epub 2011 Jan 22.

PMID: 21256568 [PubMed - indexed for MEDLINE]

A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.

Thuret R, Sun M, Lughezzani G, Budaus L, Liberman D, Abdollah F, Morgan M, Johal R, Jeldres C, Latour M, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.

Ann Surg Oncol. 2011 Feb;18(2):439-46. Epub 2010 Sep 14.

PMID: 20839061 [PubMed - indexed for MEDLINE]

Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.

Thuret R, Sun M, Abdollah F, Budaus L, Lughezzani G, Liberman D, Morgan M, Johal R, Jeldres C, Latour M, Shariat SF, Iborra F, Guiter J, Patard JJ, Perrotte P, Karakiewicz PI.

J Urol. 2011 Feb;185(2):501-7. Epub 2010 Dec 17.

PMID: 21167526 [PubMed - indexed for MEDLINE]

A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer.

Lughezzani G, Sun M, Shariat SF, Budäus L, Thuret R, Jeldres C, Liberman D, Montorsi F, Perrotte P, Karakiewicz PI.

Cancer. 2011 Jan 1;117(1):103-9. doi: 10.1002/cncr.25345. Epub 2010 Aug 27.

PMID: 20803606 [PubMed - indexed for MEDLINE] Free Article

Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.

Auprich M, Chun FK, Ward JF, Pummer K, Babaian R, Augustin H, Luger F, Gutschi S, Budäus L, Fisch M, Huland H, Graefen M, Haese A.

Eur Urol. 2011 Jan;59(1):96-105. Epub 2010 Oct 20.

PMID: 20980098 [PubMed - indexed for MEDLINE]

Gleason 6 prostate cancer in one or two biopsy cores can harbor more aggressive disease.

Katz MH, Shikanov S, Sun M, Abdollah F, Budaeus L, Gong EM, Eggener SE, Steinberg GD, Zagaja GP, Shalhav AL, Karakiewicz PI, Zorn KC.

J Endourol. 2011 Apr;25(4):699-703. Epub 2011 Jan 12.

No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe.

Stieler K, Schindler S, Schlomm T, Hohn O, Bannert N, Simon R, Minner S, Schindler M, Fischer N.

PLoS One. 2011;6(10):e25592. Epub 2011 Oct 12.

PMID: 22022417 [PubMed - indexed for MEDLINE]

Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and systems biology network platform.

Ummanni R, Mundt F, Pospisil H, Venz S, Scharf C, Barett C, Fälth M, Köllermann J, Walther R, Schlomm T, Sauter G, Bokemeyer C, Sültmann H, Schuppert A, Brümmendorf TH, Balabanov S.

PLoS One. 2011 Feb 11;6(2):e16833.

PMID: 21347291 [PubMed - indexed for MEDLINE]

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

Catto JW, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, Hamdy FC, Kallioniemi O, Mengual L, Schlomm T, Visakorpi T.

Eur Urol. 2011 May;59(5):671-81. Epub 2011 Feb 1. Review.

PMID: 21296484 [PubMed - indexed for MEDLINE]

Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.

Ummanni R, Jost E, Braig M, Lohmann F, Mundt F, Barett C, Schlomm T, Sauter G, Senff T, Bokemeyer C, Sültmann H, Meyer-Schwesinger C, Brümmendorf TH, Balabanov S.

Mol Cancer. 2011 Oct 14;10:129.

PMID: 21999842 [PubMed - indexed for MEDLINE]

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling.

Brase JC, Johannes M, Mannsperger H, Fälth M, Metzger J, Kacprzyk LA, Andrasiuk T, Gade S, Meister M, Sirma H, Sauter G, Simon R, Schlomm T, Beissbarth T, Korf U, Kuner R, Sültmann H.

BMC Cancer. 2011 Dec 5;11:507.

PMID: 22142399 [PubMed - indexed for MEDLINE]

Tumour markers in prostate cancer III: biomarkers in urine.

Roobol MJ, Haese A, Bjartell A.

Acta Oncol. 2011 Jun;50 Suppl 1:85-9. Review.

PMID: 21604945 [PubMed - indexed for MEDLINE]

Haemodynamics and cardiac function during robotic-assisted laparoscopic prostatectomy in steep Trendelenburg position.

Haas S, Haese A, Goetz AE, Kubitz JC.

Int J Med Robot. 2011 Dec;7(4):408-13. doi: 10.1002/rcs.410. Epub 2011 Aug 3.

PMID: 21815239 [PubMed - indexed for MEDLINE]

Circulating miRNAs are correlated with tumor progression in prostate cancer.

Brase JC, Johannes M, Schlomm T, Fälth M, Haese A, Steuber T, Beissbarth T, Kuner R, Sültmann H.

Int J Cancer. 2011 Feb 1;128(3):608-16.

PMID: 20473869 [PubMed - indexed for MEDLINE]

Hemodynamic effects of orally administered delta-ALA during radical prostatectomy.

Eichhorn V, Maerz A, Salomon G, Blanc IF, Reuter DA, Goetz AE.

World J Urol. 2011 Nov 26. [Epub ahead of print]

PMID: 22120180 [PubMed - as supplied by publisher]

Sequenztherapie beim metastasierten Nierenzellkarzinom in Deutschland 2010 – Bedeutung der verschiedenen Target-Substanzen

Siebels M, Hegele A, Varga Z, Oberneder R, Doehn C, Heinzer H; Deutsche Gesellschaft für Immun- und Targeted Therapie e.V. (DGFIT).

Urologe A. 2011 Sep;50(9):1110-7. German.

PMID: 21559917 [PubMed - indexed for MEDLINE]

Prostataspezifisches Antigen zur Therapiesteuerung.

Graefen M, Fröhner M, Wirth M.

Urologe A. 2011 Mar;50(3):309-12. German.

PMID: 21365346 [PubMed - indexed for MEDLINE]

Salvage radical prostatectomy in 2011: an established therapeutic option?

Graefen M.

Eur Urol. 2011 Aug;60(2):211-3. Epub 2011 Apr 30. No abstract available.

PMID: 21565441 [PubMed - indexed for MEDLINE]

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy.

Minner S, Enodien M, Sirma H, Luebke AM, Krohn A, Mayer PS, Simon R, Tennstedt P, Müller J, Scholz L, Brase JC, Liu AY, Schlüter H, Pantel K, Schumacher U, Bokemeyer C, Steuber T, Graefen M, Sauter G, Schlomm T.

Clin Cancer Res. 2011 Sep 15;17(18):5878-88. Epub 2011 Jul 26.

PMID: 21791629 [PubMed - indexed for MEDLINE]

Psychosoziale Einflussfaktoren für die Inanspruchnahme medizinischer Rehabilitationsmaßnahmen bei Patienten mit einer Prostatakrebserkrankung

Lehmann C, Beierlein V, Hagen-Aukamp C, Kerschgens C, Rhee M, Frühauf S, Otto J, Graefen M, Krüll A, Berger D, Koch U, Bergelt C.

Rehabilitation (Stuttg). 2011 Dec 15. [Epub ahead of print] German.

PMID: 22174099 [PubMed - as supplied by publisher]

Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer.

Minner S, Kraetzig F, Tachezy M, Kilic E, Graefen M, Wilczak W, Bokemeyer C, Huland H, Sauter G, Schlomm T.

Hum Pathol. 2011 Dec;42(12):1946-52. Epub 2011 Jun 17.

PMID: 21683980 [PubMed - indexed for MEDLINE]

Surgical anatomy of the prostate in the era of radical robotic prostatectomy.

Walz J, Graefen M, Huland H.

Curr Opin Urol. 2011 May;21(3):173-8. Review.

PMID: 21311334 [PubMed - indexed for MEDLINE]

Magnetic resonance imaging of prostate cancer: diffusion-weighted imaging in comparison with sextant biopsy.

Yamamura J, Salomon G, Buchert R, Hohenstein A, Graessner J, Huland H, Graefen M, Adam G, Wedegaertner U.

J Comput Assist Tomogr. 2011 Mar-Apr;35(2):223-8.

PMID: 21412094 [PubMed - indexed for MEDLINE]

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

Minner S, Wittmer C, Graefen M, Salomon G, Steuber T, Haese A, Huland H, Bokemeyer C, Yekebas E, Dierlamm J, Balabanov S, Kilic E, Wilczak W, Simon R, Sauter G, Schlomm T.

Prostate. 2011 Feb 15;71(3):281-8. doi: 10.1002/pros.21241. Epub 2010 Aug 31.

PMID: 20809553 [PubMed - indexed for MEDLINE]

Prostate cancer detection and dutasteride: utility and limitations of prostate-specific antigen in men with previous negative biopsies.

van Leeuwen PJ, Kölble K, Huland H, Hambrock T, Barentsz J, Schröder FH.

Eur Urol. 2011 Feb;59(2):183-90. Epub 2010 Dec 4. Review.

PMID: 21130560 [PubMed - indexed for MEDLINE]

MR Imaging of Prostate Cancer: Diffusion Weighted Imaging and (3D) Hydrogen 1 (H) MR Spectroscopy in Comparison with Histology.

Yamamura J, Salomon G, Buchert R, Hohenstein A, Graessner J, Huland H, Graefen M, Adam G, Wedegaetner U.

Radiol Res Pract. 2011;2011:616852. Epub 2010 Jul 20.

PMID: 22091382 [PubMed]

Seitenanfang

Seite drucken

Hauptnavigation:

Publikationen 2011